首頁(yè) 資訊 人工智能胸部X光解決方案提升ICU和ER護(hù)理途徑

人工智能胸部X光解決方案提升ICU和ER護(hù)理途徑

來(lái)源:泰然健康網(wǎng) 時(shí)間:2024年12月30日 04:33

Pneumothorax (PTX), a condition where air collects in the pleural space and causes lung collapse, and pleura effusion (PE) in which fluid accumulates in the pleural cavity, create serious challenges in emergency rooms and intensive care units (ICUs). Now, an AI-enabled chest X-ray solution has received 510(k) FDA clearance to triage PTX and PE..

氣胸(PTX)是一種空氣在胸膜腔內(nèi)聚集并導(dǎo)致肺部塌陷的疾病,胸腔積液(PE)在胸腔內(nèi)積聚,對(duì)急診室和重癥監(jiān)護(hù)病房(ICU)構(gòu)成嚴(yán)峻挑戰(zhàn)?,F(xiàn)在,啟用AI的胸部X光解決方案已獲得510(k)FDA批準(zhǔn),以對(duì)PTX和PE進(jìn)行分類(lèi)。。

Qure.ai (Mumbai, MH, India) has secured 510(k) FDA clearance for its artificial intelligence-powered chest X-ray solution, known as qXR, specifically for the rapid identification of PTX and PE. This new clearance adds to the company's existing FDA-approved product range, which includes solutions like qXR-BT for breathing tube positioning, qER for emergency room head CT scans, and qER-Quant for head CT quantification software.

Qure.ai(孟買(mǎi),MH,印度)已獲得510(k)FDA批準(zhǔn),用于其人工智能胸部X光解決方案,稱(chēng)為qXR,專(zhuān)門(mén)用于快速識(shí)別PTX和PE。這一新的許可增加了該公司現(xiàn)有的FDA批準(zhǔn)的產(chǎn)品范圍,其中包括qXR BT等呼吸管定位解決方案,qER用于急診室頭部CT掃描,和qER Quant用于頭部CT定量軟件。

qXR is designed to integrate seamlessly into current healthcare pathways, enhancing both ICU and ER operational efficiency. Clinical evaluations of qXR's effectiveness in identifying PTX have demonstrated outstanding accuracy in providing rapid passive notifications that take an average of just 10 seconds to reach healthcare staff..

qXR旨在無(wú)縫集成到當(dāng)前的醫(yī)療保健途徑中,提高ICU和ER的運(yùn)營(yíng)效率。qXR在識(shí)別PTX方面的有效性的臨床評(píng)估已經(jīng)證明在提供快速被動(dòng)通知方面具有出色的準(zhǔn)確性,平均需要10秒才能到達(dá)醫(yī)務(wù)人員。。

Such rapid alerting capabilities make qXR-PTX-PE an invaluable asset for timely medical decision-making, particularly in critical settings like ICUs and emergency departments. The technology employs a training dataset gathered from multiple global sources and fits seamlessly into the current standard healthcare protocols, acting as a passive notification system for prioritizing tasks.

這種快速的警報(bào)功能使qXR-PTX-PE成為及時(shí)醫(yī)療決策的寶貴資產(chǎn),特別是在重癥監(jiān)護(hù)病房和急診室等關(guān)鍵環(huán)境中。該技術(shù)采用從多個(gè)全球來(lái)源收集的訓(xùn)練數(shù)據(jù)集,無(wú)縫地融入當(dāng)前的標(biāo)準(zhǔn)醫(yī)療協(xié)議,作為優(yōu)先考慮任務(wù)的被動(dòng)通知系統(tǒng)。

A multi-center study assessing overlooked and incorrectly labeled chest X-ray findings for conditions like PTX and PE showed that the qXR algorithm achieved up to 96% sensitivity and 100% specificity..

一項(xiàng)多中心研究評(píng)估了PTX和PE等疾病被忽視和錯(cuò)誤標(biāo)記的胸部X線(xiàn)檢查結(jié)果,結(jié)果顯示qXR算法的靈敏度高達(dá)96%,特異性高達(dá)100%。。

“Speaking to physicians and hospital CEOs, we have heard the increasing need to reduce time to diagnosis.' said Prashant Warier, CEO and Co-Founder of Qure. The FDA clearance of the qXR algorithm further demonstrates Qure’s commitment to addressing these challenges by optimizing healthcare delivery in time-sensitive settings like the ICU and ER.”.

“與醫(yī)生和醫(yī)院首席執(zhí)行官交談,我們聽(tīng)說(shuō)越來(lái)越需要縮短診斷時(shí)間。”Qure首席執(zhí)行官兼聯(lián)合創(chuàng)始人Prashant Warier說(shuō),F(xiàn)DA批準(zhǔn)qXR算法進(jìn)一步證明了Qure致力于通過(guò)在ICU和ER等時(shí)間敏感的環(huán)境中優(yōu)化醫(yī)療服務(wù)來(lái)應(yīng)對(duì)這些挑戰(zhàn)“。

IMRT Thorax PhantomCIRS Model 002LFC

IMRT Thorax Phantom CIRS型號(hào)002LFC

Conductive GelTensive

導(dǎo)電凝膠張力

Advanced Radiotherapy SystemuRT-linac 306

先進(jìn)的放射治療系統(tǒng)uRT linac 306

Bladder ScannerZ5 Bladder Scanner

膀胱掃描儀Z5膀胱掃描儀

相關(guān)知識(shí)

智能職工健康管理系統(tǒng),提升工作效率的新途徑
情緒智力培養(yǎng):提升情緒管理能力的途徑
基于人工智能的全方位健康解決方案
智能健康解決方案
智慧門(mén)店解決方案
智能嬰兒監(jiān)護(hù)解決方案
健康管理解決方案
彌合醫(yī)療保健公平差距:人工智能倫理和包容性健康解決方案
智慧養(yǎng)老解決方案
健康智能小屋解決方案

網(wǎng)址: 人工智能胸部X光解決方案提升ICU和ER護(hù)理途徑 http://m.u1s5d6.cn/newsview918915.html

推薦資訊